Directory
>
Eric Shaff
Eric Shaff
Senior Analyst | Seres Therapeutics
Massachusetts, Cambridge, United States
Eric Shaff
Summary
Eric Shaff is an accomplished executive with over 20 years of experience in the biotechnology and healthcare sectors. As the President and CEO of Seres Therapeutics, he is dedicated to revolutionizing disease treatment through microbiome therapies. His extensive background spans corporate finance, capital markets, and corporate development, highlighting his strategic leadership capabilities. Eric's tenure at prominent firms like Sanofi and Momenta Pharmaceuticals has equipped him with a robust understanding of both operational and financial aspects of the biotech industry. He holds an MBA in Finance from Cornell University and a BA in Economics and Political Science from the University of Pennsylvania. Eric's passion for innovation and commitment to scientific discovery drive his vision for advancing healthcare solutions. He is also involved in corporate governance as a Corporate Director at Sigilon Therapeutics, further showcasing his leadership influence in the field.
Eric Shaff
Work Experience
President, Chief Executive Officer at
Seres Therapeutics
January 2019 - Present
Eric Shaff
Education
Cornell Johnson Graduate School of Management, MBA, Finance
January 2002 - January 2004
Belmont Hill
January 1990 - January 1994
University of Pennsylvania, BA, Economics, Political Science
January 1994 - January 1998
Frequently Asked Questions about Eric Shaff
What is Eric Shaff email address?
Eric Shaff's primary email address is **********@sigilon.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Eric Shaff work for?
Eric Shaff is a Senior Analyst at Seres Therapeutics.
Where Eric Shaff graduated from?
Eric Shaff holds a degree in null from Cornell Johnson Graduate School of Management.
How can I directly contact Eric Shaff?
To contact Eric Shaff directly, you can use the email address **********@sigilon.com. Complete contact information is available upon registration with Muraena.
Who is Eric Shaff?
Eric Shaff is an accomplished executive with over 20 years of experience in the biotechnology and healthcare sectors. As the President and CEO of Seres Therapeutics, he is dedicated to revolutionizing disease treatment through microbiome therapies. His extensive background spans corporate finance, capital markets, and corporate development, highlighting his strategic leadership capabilities. Eric's tenure at prominent firms like Sanofi and Momenta Pharmaceuticals has equipped him with a robust understanding of both operational and financial aspects of the biotech industry. He holds an MBA in Finance from Cornell University and a BA in Economics and Political Science from the University of Pennsylvania. Eric's passion for innovation and commitment to scientific discovery drive his vision for advancing healthcare solutions. He is also involved in corporate governance as a Corporate Director at Sigilon Therapeutics, further showcasing his leadership influence in the field.
Eric`s contact details
**********@sigilon.com
******@serestherapeutics.com
Colleagues
Research Associate
Medical Assistant & Grant Coordinator
3M Science and Technology Fellow
Market Access/Health Outcomes
Senior Clinical Associate
Manager
Senior Research Program Coordinator
Master of Accounting Candidate
Histology Research
Manager, Clinical Data Management